PALISADE BIO, INC.

PALI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-10.4M
Depreciation & Amortization $88.7K
Depreciation
Amortization
Stock-Based Compensation $4.6M
Net Cash from Operating Activities $-5.1M
Investing Activities
Capital Expenditures $88.4K
Business Acquisitions
Net Cash from Investing Activities $-210.8K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $2.8M
Net Change in Cash $-2.6M
Free Cash Flow $-5.2M
← Newer Page 3 of 3 Older →